284 - Pulpotomy Using Ferric Sulfate with and without Zinc Oxide Eugenol

Purpose: This randomized controlled clinical trial aimed to evaluate the effect of eugenol and non-eugenol-based Zinc Oxide Eugenol (ZOE) cements on primary tooth pulpotomies where Ferric Sulfate (FS) is used as a medicament.

Methods: Children aged 3-7 years with dental caries in their primary molars that have clinical and radiographic diagnosis of reversible pulpitis and undergoing dental treatment under Oral Conscious Sedation (OCS) or General Anesthesia (GA) were recruited. Children were randomly assigned to receive either FS and ZOE or FS and non-eugenol base material. The outcomes were failure rates based on clinical or radiographic evidence of pulp degeneration, pathologic mobility, swelling or fistula, spontaneous pain, tenderness to percussion or palpation, internal root resorption, inter radicular or periapical radiolucency.

Results: A total of 61 patients were recruited and 19 were treated per protocol. 33 ultimately received an alternative treatment in lieu of pulpotomy (i.e. extraction or indirect pulp cap). Of the 19 patients treated per protocol, 7 have returned for their follow-up. 2 received Pulpotomy with FS+IRM (29%) and the remaining 5 received Pulpotomy with FS+ CAVIT (71%).

Conclusion: At 6 months, in primary molars pulpotomy, non-eugenol-based ZOE placed over ferric sulphate shows similar success to using eugenol-based zinc oxide as a base material.


Identify Supporting Agency and Grant Number: